ALFA, S.A.B. DE C.V. FOURTH QUARTER 2017 FINANCIAL REPORT ALFA REPORTS 4Q17 EBITDA OF US $568 MILLION Monterrey, N.L., Mexico, February 12, 2018.- ALFA, S.A.B. de C.V. (ALFA), a leading Mexican industrial company, reported today its 4Q17 unaudited financial results. Total revenues were US $4,297 million, up 11% year-on-year due to higher sales achieved at all business units. EBITDA was US $568 million, up 5% vis-à-vis 4Q16. Commenting on the Company s results Mr. Alvaro Fernandez, ALFA s President, said: Our businesses performed better during 4Q17. At Alpek, higher margins in both business segments drove results, Sigma saw growth in all regions where it operates, while Axtel improved its Enterprise and Government segment and benefitted from tower sales. Nemak, however, continued to be affected by lower activity in the US auto industry, negative price lag and higher launch expenses. Consolidated capital expenditures and acquisitions amounted to US $250 million during 4Q17. Net Debt at the quarter end of US $6,300 million was 8% higher when compared to the US $5,844 million in 4Q16. At the end of the quarter, financial ratios were: Net Debt to EBITDA: 3.1 times; Interest Coverage: 4.6 times. Majority Net Loss was US $31 million in 4Q17, an improvement from the Majority Net Loss of US $59 million in 4Q16. This improvement is mainly explained by higher operating income that offset higher exchange losses. SELECTED FINANCIAL INFORMATION (US $MILLION) 4Q17 3Q17 4Q16 CH. % VS. 3Q17 CH. % VS. 4Q16 YTD. 17 YTD. 16 YTD Chg. % CONSOLIDATED REVENUES 4,297 4,278 3,874-11 16,804 15,756 7 Sigma 1,593 1,608 1,438 (1) 11 6,054 5,698 6 Alpek 1,321 1,312 1,183 1 12 5,231 4,838 8 Nemak 1,094 1,099 996-10 4,481 4,257 5 Axtel 226 211 191 7 19 822 736 12 Newpek 31 21 27 51 14 107 107 1 CONSOLIDATED EBITDA 1 568 400 540 42 5 2,018 2,322 (13) Sigma 195 179 166 9 18 676 663 2 Alpek 141 3 133-6 384 669 (43) Nemak 166 153 186 8 (11) 715 798 (10) Axtel 77 74 46 4 66 290 225 29 Newpek 3 1 12 303 (71) 3 9 (70) MAJORITY NET INCOME (31) (333) (59) 91 48 (134) 142 (194) CAPITAL EXPENDITURES & ACQ. 250 326 450 (23) (44) 1,101 1,491 (26) NET DEBT 6,300 6,545 5,844 (4) (8) 6,300 5,844 (8) Net Debt/LTM EBITDA* 3.1 3.3 2.5 LTM Interest Coverage* 4.6 5.1 6.6 * Times. UDM = Last 12 months 1 EBITDA = Operating Income + depreciation and amortization + impairment of assets. CONTENTS: Summary of Groups 2 Alfa Financial Tables 6 ALFA Groups Financial Information 10 This release may contain forward-looking information based on numerous variables and assumptions that are inherently uncertain. They involve judgments with respect to, among other things, future economic, competitive and financial market conditions and future business decisions, all of which are difficult or impossible to predict accurately. Accordingly, results could vary from those set forth in this release. The report presents unaudited financial information. Figures are presented in Mexican pesos or US Dollars, as indicated. Where applicable, peso amounts were translated into US Dollars using the average exchange rate of the months during which the operations were recorded. Financial ratios are calculated in US Dollars. Due to the rounding up of figures, small differences may occur when calculating percent changes from one period to the other.
ALFA S FOURTH QUARTER 2017 2 SUMMARY OF GROUPS PERFORMANCE DURING 4Q17 Sigma s revenues amounted to US $1,593 million, up 11% from 4Q16. All of Sigma s regions improved year-on-year, Mexico increased 10% and US sales increased 4%, both mainly driven by higher average prices to offset higher raw material price increases from previous quarters. European sales benefited from the consolidation of the September 2017 Caroli acquisition, increasing 14%. Latin America sales increased 16%, reflecting the acquisition of Supemsa completed at the end of 2Q17. Sigma reported 4Q17 EBITDA of US $195 million, up 18% year-on-year, mainly explained by the performance of the Mexican and US operations, the consolidation of Supemsa and Caroli, an extraordinary gain related to the acquisition of Caroli and a more favorable currency environment in Europe and Mexico. During 4Q17, capital expenditures and acquisitions totaled US $71 million with funds being utilized for the new plant in Burgos, Spain and other minor projects across the company. The investment in the La Bureba plant is complete and during 4Q17 had commenced production for the Spanish and other European markets. At the end of 4Q17, Net Debt was US $1,936 million, 12% higher than in 4Q16 mainly explained by the outflows related to the Bureba facility and the acquisitions of Supemsa and Caroli. Financial ratios at the end of 4Q17 were: Net Debt to EBITDA, 2.9 times; Interest Coverage, 4.7 times. (See appendix A for more comprehensive analysis of Sigma s 4Q17 financial results) Alpek s revenues for the fourth quarter totaled US $1.3 billion, up 12% year-on-year mainly due to higher average prices in both business segments. Average 4Q17 prices increased 11% when compared with 4Q16, while 4Q17 volume was up 1% year-on-year. 4Q17 EBITDA was US $141 million, including a US $16 million non-cash inventory gain. Adjusting for the inventory gain, Comparable EBITDA was US $124 million and US $117 million in 4Q17 and 4Q16, respectively. PET margin recovery and a rising feedstock price environment contributed to Comparable EBITDA growth. Accumulated EBITDA as of December 31, 2017 was US $384 million, including the US $113 million M&G A/R provision, a US $22 million non-cash inventory gain and a US $12 million one-time gain from the Selenis Canada Inc. acquisition (2016). Comparable Consolidated 2017 EBITDA totaled US $462 million, down 27% versus 2016 mainly due to the anticipated margin contraction in PP and PET, as well as the M&G PTA supply disruption. In November 2017, M&G Mexico resumed PET production under a temporary tolling agreement with Alpek, who supplies the required feedstocks (e.g. PTA and MEG) and pays a tolling fee in exchange for PET from the Altamira facility. The tolling agreement was recently complemented by a credit agreement through which Alpek will provide up to US $60 million in secured financing to M&G Mexico subject to certain conditions. The combination of tolling and credit agreement is intended to support M&G Mexico s PET operations while a permanent restructuring plan is presented to Alpek and other creditors. Alpek s priorities in M&G Mexico s restructuring process are: i) maximizing the recovery of its claims and ii) maintaining its PTA supply to the restructured entity. The restructuring process associated with the integrated PTA-PET plant that was being constructed by M&G in Corpus Christi, TX also advanced during 4Q17. M&G USA Corporation (M&G USA) filed for bankruptcy in Delaware and received approval to begin the sale of certain assets, including the Corpus Christi plant. Bidding procedures are scheduled to occur in 1Q18. Alpek s priority in M&G USA s restructuring process is to reaffirm its Corpus Christi capacity rights under the original agreements or as a bidder for the Corpus Christi assets.
ALFA S FOURTH QUARTER 2017 3 During 4Q17, Alpek accepted ContourGlobal s offer and moved forward with the sale process of its cogeneration power plants in Cosoleacaque and Altamira, Mexico. In Brazil, the CADE Court approved the acquisition of PetroquimicaSuape and Citepe from Petrobras. As part of the approval process, Alpek proposed entering into a merger control agreement (Acordo de Controle de Concentração ACC), committing to maintain an environment of effective competition. 4Q17 Capex was US $30 million, compared to US $75 million in 4Q16, as investment spending ramps down due to the completion of Alpek s strategic project program. Most of these funds were invested in the 350 MW power cogeneration plant in Altamira, Mexico, which advanced as planned and 80% of the total investment had been disbursed by the close of 2017. Net Debt as of the end of the quarter was US $1,262 million, up 21% year-on-year, driven by the investment in strategic projects, and the acquisition of a US $100 million credit related to M&G. At quarter end, financial ratios were as follows: Net Debt to EBITDA, 3.3 times; Interest Coverage, 4.8 times. Adjusting for the US $113 million M&G A/R provision, Net Debt to EBITDA was 2.5 times and Interest Coverage was 6.2 times. (See appendix B for Alpek s 4Q17 financial report) Nemak s 4Q17 sales volume was 12 million equivalent units, 2% higher than 4Q16, mainly due to higher customer demand in Europe for Nemak components, where volume increased 6% y-o-y reflecting the strength of the market. Meanwhile, North America volumes remained steady as new program launches compensated for lower customer production. Likewise, in Rest of the World, industry recovery in South America compensated for lower customer demand in Asia for Nemak components. Revenues were US $1,094 million, up 10% year-over-year, supported by higher volumes and higher aluminum prices. In turn, 4Q17 EBITDA totaled US $166 million, down 11% year-on-year, mainly as a result of negative metal price lag and increased expenses related to new program launches. EBITDA per unit was US $13.8 in 4Q17, down from US $15.8 in the same period last year. Capital expenditures in the quarter amounted to US $109 million as the company continued with investments to increase and adapt production capacity to meet new demand related to recently won contracts. Likewise, resources were invested in the continued ramp-up of new programs to produce structural and electric vehicle components in NA and EU. Net Debt at the end of 4Q17 totaled US $1,271 million, up 1% from 4Q16, reflecting the capital expenditures during the period. Financial ratios in 4Q17 were: Net Debt to EBITDA of 1.8 times, and Interest Coverage of 11.2 times. (See appendix C for Nemak s 4Q17 financial report) Axtel s revenues in the fourth quarter totaled US $226 million, up 19% year-on-year, mainly explained by the performance from the core Enterprise and Government segment, while in the Mass Market segment FTTx revenues were not enough to offset the decline of its legacy Wimax business. In peso terms, total revenues increased 13% in the quarter. Enterprise and Government segment represented 83% of revenues in the quarter. 4Q17 EBITDA was US $77 million, up 66% year-on-year, explained in part by a US $18 million benefit from the third tranche of the transmission tower sale. Excluding this effect, EBITDA increased 26% from 4Q16, mainly due to a better performance from the Enterprise and Government segment. Capital expenditures totaled US $23 million in 4Q17 (US $41 million excluding tower sales), including investments to provide last-mile access to connect customers, to deploy IT infrastructure and to further increase data center capacity in Queretaro, Mexico. At the end of 4Q17, Net Debt was US $973 million, similar year-on-year. Financial ratios at the end of 4Q17 were: Net Debt to EBITDA of 3.4 times and Interest Coverage of 3.4 times.
ALFA S FOURTH QUARTER 2017 4 (See appendix D for Axtel s 4Q17 financial report) Newpek s revenues were US $31 million, up 14% from 4Q16, helped by higher production and higher average oil prices. Newpek connected to sales nine new wells at the Eagle Ford Shale ( EFS ) in South Texas. This brought wells in production at EFS to 648 by the quarter s end, compared to the 628 wells in production at the end of 4Q16. Production in the US averaged 6.2 thousand barrels of oil equivalent per day (MBOED) during 4Q17, up 4% from 4Q16. Strategic drilling and completion activities continued at EFS during the quarter. A total of 20 new producing wells were connected to sales during the year. Additionally, five new wells were drilled and completed in the Wilcox formation in South Texas, where Newpek has a 20% working interest. In Mexico, production averaged 3.4 MBOED during 4Q17, down 3% from 4Q16. 4Q17 EBITDA was US $3 million, down 71% year-on-year, as 4Q16 benefitted by extraordinary income. Capital expenditures amounted to US $13 million, while net debt was US $34 million at the end of the quarter. (See appendix E for more comprehensive analysis of Newpek s 4Q17 financial results) CONSOLIDATED FINANCIAL RESULTS 4Q17 consolidated revenues were US $4,297 million, up 11% from US $3,874 million reported in 4Q16. The increase is the result of higher sales across all business units and mainly reflects higher volumes and prices in Sigma, Alpek and Nemak. During the quarter, foreign sales represented 66% of the total, slightly higher than 4Q16. For full year 2017, revenues were US $16,804, up 7% from 2016 mainly explained by higher volume and prices in Sigma and Alpek, and by higher aluminum prices which compensated lower volumes in Nemak. 4Q17 Consolidated Operating Income totaled US $288 million, up 50% from US $192 million in 4Q16. Factors contributing to this result were: higher polyester and polypropylene margins in Alpek, and a US $16 million inventory gain as a result of higher oil and feedstock prices; in Sigma, better performance in all regions and the contribution from the acquisitions of Supemsa and Caroli during the year; in Axtel, growth in the Enterprise and Government segment, as well as extraordinary income of US $18 million stemming from the sale of transmission towers. In turn, Nemak s Operating Income was impacted by negative metal price lag and higher launch expenses. Reported accumulated Operating Income was US $557 million, down 58% from 2016, mainly attributable to the impairments recorded in Alpek during 3Q17, related to the financial difficulties at Mossi & Ghisolfi (M&G), its main client. Excluding these costs, operating income was US $1,105 million, down 16% from 2016. 4Q17 EBITDA was US $568 million, up 5% year-on-year, reflecting the higher Operating Income explained above. Year-todate EBITDA was US $2,018 million, down 13% from 2016, explained mainly by the impairment of accounts receivable recorded at Alpek in 3Q17, related to the financial difficulties at M&G. ALFA reported 4Q17 Comprehensive Financing Expense (CFE) of US $329 million, compared to US $183 million in 4Q16, mainly explained by higher foreign exchange losses during the quarter, as compared to 4Q16. Majority Net Loss was US $31 million in 4Q17, compared to Majority Net Loss of US $59 million in 4Q16. This year-on-year improvement is mainly explained by higher Operating Income that offset the increase in Comprehensive Financing Expense ( CFE ) already explained. Year-to-date Majority Net Loss was US $134 million, down 194% from the same period in 2016, reflecting mainly the effects of provisions and asset impairments at Alpek which impacted both Operating Income and Comprehensive Financing Expense ( CFE ) in 3Q17.
ALFA S FOURTH QUARTER 2017 5 CAPITAL EXPENDITURES AND ACQUISITIONS; NET DEBT Consolidated capital expenditures and acquisitions totaled US $250 million in 4Q17. All subsidiaries continued to make progress on their investment plans as discussed in the initial section of this report. At quarter-end 4Q17, ALFA s Net Debt amounted to US $6,300 million, US $456 million higher than 4Q16. At the end of the quarter, financial ratios were: Net Debt to EBITDA, 3.1 times; Interest Coverage, 4.6 times. These ratios compare to 2.5 times and 6.6 times, respectively in 4Q16.
ALFA S FOURTH QUARTER 2017 6 ALFA TABLE 1 VOLUME AND PRICE CHANGES (%) 4Q17 vs. YTD. 17 VS 3Q17 4Q16 YTD. 16 Total Volume 1.5 8.6 7.7 Domestic Volume (0.1) 10.0 12.6 Foreign Volume 3.2 7.3 3.2 Avg. Ps. Prices 5.1 (2.4) 0.4 Avg. US $ Prices (1.0) 2.1 (1.0) TABLE 2 REVENUES (%) 4Q17 VS. 4Q17 3Q17 4Q16 3Q17 4Q16 YTD. 17 YTD. 16 Ch.% TOTAL REVENUES Ps. Millions 81,345 76,235 76,713 7 6 317,627 293,782 8 US $ Millions 4,297 4,278 3,874-11 16,804 15,756 7 DOMESTIC REVENUES Ps. Millions 27,590 26,719 27,213 3 1 110,615 103,290 7 US $ Millions 1,457 1,499 1,373 (3) 6 5,853 5,539 6 FOREIGN REVENUES Ps. Millions 53,755 49,516 49,500 9 9 207,012 190,492 9 US $ Millions 2,840 2,779 2,500 2 14 10,951 10,217 7 Foreign / Total (%) 66 65 65 65 65 TABLE 3 OPERATING INCOME AND EBITDA (%) 4Q17 VS. 4Q17 3Q17 4Q16 3Q17 4Q16 YTD. 17 YTD. 16 Ch.% OPERATING INCOME Ps. Millions 5,447 (5,367) 3,734 202 46 11,195 24,214 (54) US $ Millions 288 (302) 192 196 50 557 1,313 (58) EBITDA Ps. Millions 10,751 7,134 10,709 51-38,312 43,254 (11) US $ Millions 568 400 540 42 5 2,018 2,322 (13) TABLE 4 COMPREHENSIVE FINANCING (EXPENSE) / INCOME (CFI) (US $ MILLIONS) (%) 4Q17 VS. 4Q17 3Q17 4Q16 3Q17 4Q16 YTD. 17 YTD. 16 Ch.% Financial Expenses (140) (114) (70) (22) (99) (493) (384) (29) Financial Income 27 8 9 233 186 55 31 77 Net Financial Expenses (113) (106) (61) (6) (86) (438) (352) (25) Fx Gains (Losses) (223) (74) (127) (201) (76) (80) (383) 79 Financial Asset Impairment 0 (95) 0 (100) - (95) 0 (100) PRE valuation 0 0 0 - - 0 (69) 100 Capitalized CFE 7 4 5 65 52 18 6 198 CFE (329) (271) (183) (21) (80) (595) (798) 25 Avg. Cost of Borrowed Funds (%) 4.9 4.8 4.9 5.0 4.8
ALFA S FOURTH QUARTER 2017 7 ALFA TABLE 5 MAJORITY NET INCOME (US $ MILLIONS) (%) 4Q17 VS. 4Q17 3Q17 4Q16 3Q17 4Q16 YTD. 17 YTD. 16 Ch.% Consolidated Net Income (Loss) (44) (417) (54) 89 18 (109) 276 (140) Minority Interest (13) (83) 6 84 (327) 25 134 (82) Majority Net Income (Loss) (31) (333) (59) 91 48 (134) 142 (194) Per Share (US Dollars) (0.01) (0.07) (0.01) (540) (2,608) (0.03) 0.03 (151) Avg. Outstanding Shares (Millions) 5,067 5,086 5,121 5,088 5,121 TABLE 6 CASH FLOW (US $ MILLIONS) (%) 4Q17 VS. 4Q17 3Q17 4Q16 3Q17 4Q16 YTD. 17 YTD. 16 Ch.% EBITDA 568 400 540 42 5 2,018 2,322 (13) Net Working Capital & Others 315 56 232 463 36 97 (71) 237 Capital Expenditures & Acquisitions (250) (326) (450) 23 44 (1,101) (1,491) 26 Net Financial Expenses (135) (103) (60) (31) (125) (465) (369) (26) Taxes (57) (57) (58) - 2 (255) (290) 12 Dividends (ALFA, S.A.B.) 0 0 0 - - (170) (172) 1 Other Sources / Uses (196) (114) (105) (72) (87) (580) (987) 41 Decrease (Increase) in Net Debt 245 (144) 99 270 147 (456) (1,059) 57 TABLE 7 SELECTED BALANCE SHEET INFORMATION & FINANCIAL RATIOS (US $ MILLIONS) 4Q17 3Q17 4Q16 YTD. 17 YTD. 16 Assets 18,189 18,002 16,868 18,189 16,868 Liabilities 13,506 13,182 11,999 13,506 11,999 Stockholders Equity 4,683 4,821 4,869 4,683 4,869 Majority Equity 3,518 3,608 3,667 3,518 3,667 Net Debt 6,300 6,545 5,844 6,300 5,844 Net Debt/EBITDA* 3.1 3.3 2.5 3.1 2.5 Interest Coverage* 4.6 5.1 6.6 4.6 6.6 * Times: LTM = Last 12 months
Appendix A ALFA, S.A.B. de C.V. and Subsidiaries BALANCE SHEET Information in millions of Nominal Mexican Pesos (%) Dec 17 vs. Dec-17 Jun-17 Dec-16 Sep 17 Dec 16 ASSETS CURRENT ASSETS: Cash and cash equivalents 32,813 23,646 24,633 39 33 Trade accounts receivable 27,621 26,180 28,850 6 (4) Other accounts and notes receivable 7,286 6,816 6,441 7 13 Inventories 44,341 40,515 40,923 9 8 Other current assets 10,074 11,633 10,921 (13) (8) Total current assets 122,135 108,790 111,768 12 9 INVESTMENTS IN ASSOCIATES AND JOINT VENTURES 1,455 1,299 2,111 12 (31) PROPERTY, PLANT AND EQUIPMENT 153,642 143,556 149,503 7 3 INTANGIBLE ASSETS 58,058 53,433 63,171 9 (8) OTHER NON-CURRENT ASSETS 23,678 20,529 22,009 15 8 Total assets 358,968 327,607 348,562 10 3 LIABILITIES AND STOCKHOLDER'S EQUITY CURRENT LIABILITIES: Current portion of long-term debt 2,454 2,591 2,614 (5) (6) Bank loans and notes payable 12,692 11,149 6,193 14 105 Suppliers 61,214 51,131 53,729 20 14 Other current liabilities 21,834 20,176 20,470 8 7 Total current liabilities 98,194 85,048 83,006 15 18 LONG-TERM LIABILITIES: Long-term debt 143,816 130,865 136,323 10 5 Deferred income taxes 13,874 13,577 16,228 2 (15) Other liabilities 5,677 5,759 7,890 (1) (28) Estimated liabilities for seniority premiums and pension plans 4,982 4,626 4,502 8 11 Total liabilities 266,542 239,876 247,950 11 7 STOCKHOLDERS' EQUITY: Controlling interest: Capital stock 211 212 213 (1) (1) Contributed capital 211 212 213 (1) (1) Earned surplus 69,227 65,445 75,562 6 (8) Total controlling interest 69,437 65,657 75,776 6 (8) Total Non-controlling interest 22,989 22,073 24,837 4 (7) Total stockholders' equity 92,427 87,731 100,613 5 (8) Total liabilities and stockholders' equity 358,968 327,607 348,563 10 3 Current ratio 1.24 1.28 1.35 Debt to equity 2.88 2.73 2.46
Appendix B ALFA, S.A.B. DE C.V. and Subsidiaries STATEMENT OF COMPREHENSIVE INCOME Information in millions of Nominal Mexican Pesos 4Q17 vs. (%) 4Q17 3Q17 4Q16 YTD '17 YTD '16 3Q17 4Q16 Net sales 81,345 76,235 76,713 317,627 293,782 7 6 Domestic 27,590 26,719 27,213 110,615 103,290 3 1 Export 53,755 49,516 49,500 207,012 190,492 9 9 Cost of sales (64,817) (61,368) (59,773) (254,284) (226,422) (6) (8) Gross profit 16,528 14,867 16,940 63,344 67,360 11 (2) Operating expenses and others (11,081) (20,233) (13,206) (52,149) (43,146) 45 16 Operating income 5,447 (5,367) 3,734 11,195 24,214 202 46 Comprehensive financing expense, net (6,222) (4,823) (3,711) (10,912) (15,058) (29) (68) Equity in income (loss) of associates 17 5 77 92 115 220 (78) Income before the following provision (758) (10,184) 100 375 9,271 93 (856) Provisions for: Income tax (83) 2,759 (1,274) (1,803) (4,536) (103) 93 Consolidated net income (841) (7,426) (1,173) (1,427) 4,735 89 28 Income (loss) corresponding to minority interest (251) (1,487) 92 624 2,410 83 (374) Net income (loss) corresponding to majority interest (590) (5,939) (1,265) (2,051) 2,325 90 53 EBITDA 10,751 7,134 10,709 38,312 43,254 51 0 Interest coverage* 4.6 5.2 6.6 4.6 6.6 * LTM
ALFA S FOURTH QUARTER 2017 10 LUIS OCHOA +52 (81) 8748. 2521 lochoa@alfa.com.mx JUAN ANDRÉS MARTÍN +52 (81) 8748.1141 jamartin@alfa.com.mx APPENDIX: A SIGMA 11 B ALPEK 17 C NEMAK 30 D AXTEL 38 E NEWPEK 48 MARCELA ELIZONDO +52 (81) 8748.1223 melizondo@alfa.com.mx INSPIR GROUP SUSAN BORINELLI +1 (646) 330.5907 susan@inspirgroup.com
ALFA S FOURTH QUARTER 2017 11 SIGMA REFRIGERATED FOOD PRODUCTS 37% AND 34% OF ALFA S REVENUES AND EBITDA IN 4Q17 Sigma is a leading multinational refrigerated food company that produces, markets and distributes quality branded foods, including packaged meats, cheese, yogurt and other refrigerated and frozen foods. Sigma has a diversified portfolio of leading brands and operates 70 plants in 18 countries across its four key regions: Mexico, Europe, the United States, and Latin America. SELECTED FINANCIAL INFORMATION SELECTED FINANCIAL INFORMATION (US $MILLION) 4Q17 3Q17 4Q16 CH. % VS. 3Q17 CH. % VS. 4Q16 YTD. 17 YTD. 16 YTD Chg. % TOTAL REVENUES 1,593 1,608 1,438 (1) 11 6,054 5,698 6 Europe 607 571 534 6 14 2,146 2,027 6 Mexico 636 668 579 (5) 10 2,496 2,329 7 USA 227 251 219 (9) 4 966 935 3 Latam 123 119 106 4 16 446 407 10 TOTAL EBITDA 195 179 166 9 18 676 663 2 Europe 64 45 44 43 45 177 151 17 Mexico 84 90 76 (6) 11 322 319 1 USA 36 36 34-6 139 148 (6) Latam 11 9 11 25 (7) 38 45 (16) CAPITAL EXPENDITURES 71 34 157 106 (55) 188 328 (43) NET DEBT 1,936 2,037 1,724 (5) 12 1,936 1,724 12 Net Debt/LTM EBITDA* 2.9 3.1 2.6 2.9 2.6 LTM Interest Coverage* 4.7 4.6 5.5 4.7 5.5 * Times. UDM = Last 12 months INDUSTRY COMMENTS During 4Q17, consumer confidence was higher year-on-year across all of Sigma s main regions of operations. In Mexico, the average consumer confidence index reported by INEGI (Instituto Nacional de Estadística y Geografía National Institute for Statistics and Geography) recovered steadily throughout the year and was up 4% year-on-year, but at similar levels with 3Q17; while same-store sales reported by the National Association of Supermarkets and Department Stores (ANTAD) increased 4% year-on-year in nominal pesos. In Europe, according to the European Commission, the average consumer confidence index for 4Q17 improved to negative 0.2, from negative 6.5 during 4Q16, reaching a 10-year high. In the U.S., the average consumer confidence index increased to 126 in 4Q17 from 108 during 4Q16 as reported by The Conference Board, the highest level since 2000. Food retail sales reported by the US Census Bureau increased 4% year-on-year. While in Europe, food retail sales increased 1%, according to Eurostat. Key raw material prices were mixed during the quarter and varied by region. In the Americas, pork prices were flat when compared to 4Q16. In turn, turkey breast and turkey thighs were 21% and 19% lower, respectively, while chicken was 19% higher than the same period of the prior year. Compared to the previous quarter, pork ham decreased 8%, while other raw materials prices were stable. In Mexico, the appreciation of the Peso vis-a-vis the US Dollar has eased the pressure in the cost of raw materials, as the industry participants import most of its meats from the US. In Europe, prices for ham decreased sharply during 4Q17 and was on average 6% lower than 4Q16, while pork shoulder was similar to 4Q16. For the full year, pork ham and pork shoulder prices in Europe were 8% and 15% higher than 2016, respectively.
ALFA S FOURTH QUARTER 2017 12 FINANCIAL RESULTS BY REGION Europe During 4Q17, European revenue in euros increased 4% year-on-year, benefiting from the consolidation of the September 2017 acquisition of Caroli in Romania. 4Q17 EBITDA increased 32% year-on-year, which includes 11 million Euros of extraordinary gain related to the acquisition of Caroli. Excluding this effect EBITDA increased 4%. For the full year 2017, sales increased 3% and EBITDA 12% compared to 2016. Yearly results in Europe were negatively impacted by start-up costs for the La Bureba plant and higher raw materials and benefited by 20 million Euros by the extraordinary gains related to the Caroli acquisition. Mexico Fourth quarter sales in Mexico in pesos increased 5% year-on-year, reflecting a slight increase in volume and higher average prices. 4Q17 EBITDA in pesos increased 6% year-on-year, benefitting from slightly higher margins than 4Q16. Sales in the Foodservice channel had a positive impact on results. For the year 2017, sales increased 8% due to higher volumes and higher average prices. EBITDA increased 2% compared to 2016. Results were impacted by lower margins at the beginning of the year caused by a sharp peso depreciation, however margins improved as price increases were implemented. USA 4Q17 U.S. sales increased 4% and EBITDA increased 6% year-on-year, as results benefited from higher average prices. Fourth quarter revenues for all three main business segments in the region grew year-on-year. For the year 2017, sales increased 3% and EBITDA decreased 6% compared to 2016. Raw materials cost increases during the first half of the year impacted EBITDA as most of the price increases flowed through during the second half of the year, which helped improve margins in the last two quarters. Latam Fourth quarter 2017 Latin America sales in USD increased 16% year-on-year, benefited from the acquisition of Supemsa at the end of 2Q17. Excluding this acquisition 4Q17 sales were flat with 4Q16. 4Q17 EBITDA decreased 7% year-on-year, mainly impacted by a reclassification of costs and expenses from Mexican operations. For the year 2017, sales in USD increased 10% and EBITDA decreased 16%. CONSOLIDATED FINANCIAL RESULTS During 4Q17, Sigma s revenues were U.S. $1,593 million, an increase of 11% versus 4Q16. Sigma sold approximately 437 thousand tons of food products, up 3% from 4Q16, mainly due to growth in Mexico and U.S., and the Caroli and Supemsa acquisitions. In dollar terms, average prices increased 8% year-on-year, stemming from higher prices in Americas regions and a weaker US dollar against the Euro and Peso. Sales in Mexico accounted for 40% of the quarter s total, while Europe represented 38%, the U.S. 14%, and Latin America 8%. During 2017, revenues were U.S. $6,054 million, up 6% when compared to the same period of 2016
ALFA S FOURTH QUARTER 2017 13 Operating Income and EBITDA were U.S. $132 million and U.S. $195 million in 4Q17, up 24% and 18% year-on-year, respectively. This increase was primarily due to the performance of Mexican and U.S. operations, the consolidation of Supemsa and Caroli, an extraordinary gain related to the acquisition of Caroli and a more favorable currency environment in Europe and Mexico. In 2017, Operating Income and EBITDA were U.S. $458 million and U.S. $676 million, unchanged and 2% higher than 2016, respectively. CAPITAL EXPENDITURES AND ACQUISITIONS; NET DEBT During 4Q17, capital expenditures were U.S. $71 million, these funds were utilized for the new plant in Burgos, Spain, other fixed assets and minor projects across the company. The investment in La Bureba plant is complete and during 4Q17 production continued for the Spanish and other European markets. At the end of 4Q17, Net Debt was U.S. $1,936 million, up 12% from 4Q16, mainly explained by the payment of the construction of the Bureba facility and the acquisitions of Supemsa and Caroli. Financial ratios at the end of 4Q17 were: Net Debt to EBITDA, 2.9 times; Interest Coverage, 4.7 times.
ALFA S FOURTH QUARTER 2017 14 SIGMA TABLE 1 VOLUME AND PRICE CHANGES (%) 4Q17 vs. YTD. 17 VS 3Q17 4Q16 YTD. 16 Total Volume (0.2) 2.8 2.5 Avg. Ps. Prices 5.5 2.9 4.8 Avg. US $ Prices (0.7) 7.8 3.7 TABLE 2 REVENUES (%) 4Q17 VS. 4Q17 3Q17 4Q16 3Q17 4Q16 YTD.17 YTD. 16 Ch.% TOTAL REVENUES Ps. Millions 30,162 28,658 28,521 5 6 114,222 106,341 7 US $ Millions 1,593 1,608 1,438 (1) 11 6,054 5,698 6 DOMESTIC REVENUES Ps. Millions 12,042 11,902 11,484 1 5 47,078 43,432 8 US $ Millions 636 668 579 (5) 10 2,496 2,329 7 FOREIGN REVENUES Ps. Millions 18,120 16,757 17,037 8 6 67,144 62,908 7 US $ Millions 957 940 859 2 11 3,558 3,369 6 Foreign / Total (%) 60 58 60 59 59 TABLE 3 OPERATING INCOME AND EBITDA (%) 4Q17 VS. 4Q17 3Q17 4Q16 3Q17 4Q16 YTD. 17 YTD. 16 Ch.% OPERATING INCOME Ps. Millions 2,495 2,229 2,095 12 19 8,591 8,519 1 US $ Millions 132 125 106 5 24 458 458 - EBITDA Ps. Millions 3,699 3,192 3,295 16 12 12,725 12,374 3 US $ Millions 195 179 166 9 18 676 663 2 TABLE 4 SELECTED BALANCE SHEET INFORMATION & FINANCIAL RATIOS (US $ MILLIONS) 4Q17 3Q17 4Q16 YTD. 17 YTD. 16 Assets 5,350 5,365 4,876 5,350 4,876 Liabilities 4,423 4,407 4,051 4,423 4,051 Stockholders Equity 927 958 825 927 825 Majority Equity 892 925 795 892 795 Net Debt 1,936 2,037 1,724 1,936 1,724 Net Debt/EBITDA* 2.9 3.2 2.6 2.9 2.6 Interest Coverage* 4.7 4.6 5.5 4.7 5.5 * Times: LTM = Last 12 months
Appendix A Sigma Alimentos, S.A. de C.V. and Subsidiaries BALANCE SHEET Information in millions of Nominal Mexican Pesos (%) Dec 17 vs. Dec-17 Sep-17 Dec-16 Sep 17 Dec 16 ASSETS CURRENT ASSETS: Cash and cash equivalents 12,807,070 10,098,380 12,837,614 27 (0) Restricted cash 84,855 149,219 123,973 (43) (32) Customers, net 5,776,360 6,201,437 6,662,529 (7) (13) Income tax recoverable 819,476 826,823 846,056 (1) (3) Inventories 14,687,050 14,583,982 13,751,274 1 7 Other current assets 2,626,694 3,168,138 2,720,783 (17) (3) Total current assets 36,801,505 35,027,980 36,942,229 5 (0) NON-CURRENT ASSETS: Property, plant and equipment, net 35,268,405 32,807,778 33,089,282 8 7 Intangible assets, net 15,714,594 14,516,197 15,753,001 8 (0) Goodwill 14,742,249 12,946,049 10,911,844 14 35 Deferred income tax 2,792,463 2,100,858 2,995,464 33 (7) Investments in associates and joint ventures 92,996 89,253 945,968 4 (90) Other non-current assets 174,005 141,838 122,980 23 41 Total non-current assets 68,784,712 62,601,972 63,818,540 10 8 Total assets 105,586,217 97,629,952 100,760,769 8 5 LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES: Current debt 2,379,616 2,470,052 442,238 (4) 438 Notes payables 70,146 65,091 57,415 8 22 Suppliers 20,866,955 18,220,841 21,376,345 15 (2) Income tax payable 1,783,816 1,739,837 667,648 3 167 Provisions 323,565 181,787 211,005 78 53 Other current liabilities 5,183,749 5,044,442 4,964,414 3 4 Total current liabilities 30,607,848 27,722,050 27,719,065 10 10 NON-CURRENT LIABILITIES: Non-current debt 48,029,505 44,108,759 47,400,372 9 1 Notes payables 313,932 314,423 345,805 (0) (9) Deferred income taxes 4,068,122 4,113,576 3,846,026 (1) 6 Employees benefits 1,339,070 1,190,334 1,117,998 12 20 Provisions 110,133 153,733 348,473 (28) (68) Income tax payable 2,341,907 2,120,911 2,460,047 10 (5) Other non-current liabilities 486,305 467,828 475,414 4 2 Total pasivo a largo plazo 56,688,973 52,469,564 55,994,135 8 1 Total liabilities 87,296,821 80,191,614 83,713,200 9 4 STOCKHOLDERS' EQUITY Total controlling interest: 17,597,331 16,828,274 16,429,586 5 7 Total non-controlling interest: 692,065 610,064 617,983 13 12 Total stockholders' equity 18,289,396 17,438,338 17,047,569 5 7 Total liabilities and stockholders' equity 105,586,217 97,629,952 100,760,769 8 5
Appendix B Sigma Alimentos, S.A. de C.V. and Subsidiaries STATEMENT OF COMPREHENSIVE INCOME Information in millions of Nominal Mexican Pesos 4Q17 vs. (%) 4Q17 3Q17 4Q16 YTD '17 YTD '16 3Q17 4Q16 Revenue 30,161,640 28,658,206 28,521,486 114,222,039 106,340,864 5 # 6 Cost of sales (21,941,195) (20,695,299) (20,602,173) (82,748,224) (75,369,775) 6 6 Gross profit 8,220,446 7,962,907 7,919,312 31,473,815 30,971,089 3 4 Selling expenses (4,676,555) (4,653,978) (4,393,911) (18,266,369) (17,397,744) 0 6 Administrative expenses (1,072,429) (1,272,425) (1,102,005) (4,780,769) (4,578,817) (16) (3) Other income (expenses), net 23,155 192,170 (328,161) 164,064 (475,656) (88) (107) Operating profit 2,494,617 2,228,675 2,095,235 8,590,741 8,518,872 12 19 Comprehensive financial expenses, net (1,057,380) (888,586) (696,620) (4,388,909) (2,756,969) 19 52 Equity in income (loss) of associates (383) 9,258 16,329 15,976 50,236 (104) (102) Profit before income tax 1,436,854 1,349,347 1,414,943 4,217,808 5,812,139 6 2 Provisions for: Income tax 257,877 (330,001) (103,932) (2,143,965) (859,554) (178) (348) Net consolidated profit 1,694,732 1,019,345 1,311,011 2,073,843 4,952,585 66 29 Non-controlling interest 22,088 12,821 13,816 41,952 33,419 72 60 Controlling interest 1,672,644 1,006,525 1,297,194 2,031,891 4,919,166 66 29
Fourth Quarter 2017 (4Q17) Monterrey, Mexico. February 12, 2018 Alpek, S.A.B. de C.V. (BMV: ALPEK) Selected Financial Information (U.S. $ Millions) Alpek reports 4Q17 EBITDA of U.S. $141 million (%) 4Q17 vs. 4Q17 3Q17 4Q16 3Q17 4Q16 YTD17 YTD16 Ch.% Total Volume (ktons) 975 1,012 970 (4) 1 4,012 3,938 2 Polyester 752 788 749 (5) - 3,105 3,004 3 Plastics & Chemicals 224 225 221-1 906 934 (3) Consolidated Revenues 1,321 1,312 1,183 1 12 5,231 4,838 8 Polyester 933 945 851 (1) 10 3,724 3,444 8 Plastics & Chemicals 388 367 332 6 17 1,506 1,394 8 Consolidated EBITDA 141 3 133 4,241 6 384 669 (43) Polyester 77 (51) 82 253 (6) 147 349 (58) Plastics & Chemicals 64 54 52 18 21 237 322 (26) Profit Attributable to Controlling Interest (30) (400) 28 92 (209) (319) 198 (261) CAPEX and Acquisitions 30 64 75 (54) (60) 236 345 (32) Net Debt 1,262 1,192 1,042 6 21 Net Debt/LTM EBITDA (1) 3.3 3.2 1.6 Interest Coverage (1) 4.8 5.4 10.5 (1) Times: Last 12 months Operating & Financial Highlights (4Q17) Alpek 4Q17 Consolidated EBITDA of U.S. $141 million, including a U.S. $16 million non-cash inventory gain; rapid recovery after 3Q17 Cogeneration power plants sale process advanced with ContourGlobal 3.3 times Net Debt/EBITDA; 2.5 times excluding M&G A/R provision (U.S. -$113 million) Polyester M&G Mexico resumed PET production in 4Q17; Alpek supplies PTA via tolling agreement and secured credit facility The Court of the Administrative Council for Economic Defense in Brazil (CADE) approved the acquisition of PetroquímicaSuape and Citepe PET antidumping cases moving forward in the United States and Canada Plastics & Chemicals (P&C) 4Q17 P&C EBITDA of U.S. $64 million, including a U.S. $5 million non-cash inventory gain Margin expansion in polypropylene (PP) and caprolactam (CPL) more than offset flat 4Q17 volume This release contains forward looking information based on numerous variables and assumptions that are inherently uncertain. They involve judgments with respect to, among other things, future economic, competitive and financial market conditions and future business decisions, all of which are difficult or impossible to predict accurately. Accordingly, results could vary from those set forth in this release. The report presents unaudited financial information based on International Financial Reporting Standards (IFRS). Figures are stated in nominal Mexican pesos ($) and in current U.S. Dollars (U.S. $), as indicated. Where applicable, peso amounts were translated into U.S. Dollars using the average exchange rate of the months during which operations were recorded. Financial ratios are calculated in U.S. Dollars. Due to the rounding up of figures, small differences may occur when calculating percent changes from one period to the other.
Fourth Quarter 2017 (4Q17) Message from the CEO Alpek s Consolidated EBITDA returned to a normalized level in the fourth quarter, supported by solid performance in both business segments. The restart of M&G Polímeros México, S.A. de C.V. (M&G Mexico), robust polypropylene (PP) margins and a rising oil price environment contributed to a rapid recovery after 3Q17. Consolidated 4Q17 EBITDA was U.S. $141 million, including a U.S. $16 million non-cash inventory gain. Higher feedstock prices resulted in an U.S. $11 million inventory gain in Polyester and a U.S. $5 million gain in Plastics & Chemicals (P&C). Adjusting for inventory gains and the U.S. -$113 million M&G A/R provision in 3Q17, Comparable 4Q17 Consolidated EBITDA was up 6% and 15% versus 4Q16 and 3Q17 respectively. Comparable 4Q17 Polyester EBITDA increased 22% quarter-on-quarter to U.S. $66 million as M&G Mexico resumed operations and PET margins posted a sequential recovery amid rising oil and feedstock prices. In addition, the P&C segment closed the year with Comparable EBITDA of U.S. $59 million, its fourth consecutive quarter above Guidance driven by higher than expected PP margins. In November 2017, M&G Mexico resumed PET production under a temporary tolling agreement with Alpek, who supplies the required feedstocks (e.g. PTA and MEG) and pays a tolling fee in exchange for PET from the Altamira facility. The tolling agreement was recently complemented by a credit agreement through which Alpek will provide up to U.S. $60 million in secured financing to M&G Mexico subject to certain conditions. The combination of tolling and credit agreement is intended to support M&G Mexico s PET operations while a permanent restructuring plan is presented to Alpek and other creditors. Alpek s priorities in M&G Mexico s restructuring process are: i) maximizing the recovery of its claims and ii) maintaining its PTA supply to the restructured entity. The restructuring process associated to the integrated PTA-PET plant that was being constructed by M&G in Corpus Christi, TX also advanced during 4Q17. M&G USA Corporation (M&G USA) filed for bankruptcy in Delaware and received approval to begin the sale of certain assets, including the Corpus Christi plant. Bidding procedures are scheduled to occur in 1Q18. Alpek s priority in M&G USA s restructuring process is to reaffirm its Corpus Christi capacity rights under the original agreements or as a bidder for the Corpus Christi assets. Other key, ongoing events include: i) the formal sale process of our two cogeneration power plants, ii) the evaluation process by the Court of the Administrative Council for Economic Defense (CADE), and iii) the PET antidumping cases in the United States and Canada. During 4Q17, Alpek selected ContourGlobal and moved forward in the sale process of its cogeneration power plants in Cosoleacaque and Altamira, Mexico. In Brazil, the CADE Court approved the acquisition of PetroquímicaSuape and Citepe from Petrobras. As part of the approval process, Alpek proposed entering into a merger control agreement (Acordo de Controle de Concentração ACC), committing to maintain an environment of effective competition. Regarding the PET antidumping cases, the United States Department of Commerce (USDOC) initiated its investigations and the United States International Trade Commission (USITC) issued a preliminary determination of material injury caused by PET imports from Brazil, Indonesia, Korea, Pakistan and Taiwan. Separately, the Canada Border Services Agency (CBSA) imposed preliminary duties ranging from 22% to 77% on PET imports from China, India, Oman and Pakistan. ir@alpek.com www.alpek.com 2
Fourth Quarter 2017 (4Q17) On the investment front, Capex was U.S. $30 million in 4Q17 and totaled U.S. $236 million in 2017, as planned. Our strategic capex program reached an important milestone this year with the start-up of two projects; the propylene storage spheres and the expandable polystyrene (EPS) capacity expansion in Mexico. Moreover, progress continued in the 350 MW Altamira cogeneration power plant as approximately 80% of the total investment had been disbursed at the close of 2017. Alpek maintains a solid financial position supported by a strong balance sheet and liquidity. At the close of 4Q17, Net Debt totaled U.S. $1.262 billion and Net Debt to EBITDA was 3.3 times or 2.5 times when adjusted for the U.S. -$113 million M&G A/R provision that affected EBITDA in 3Q17. Furthermore, the balance of Cash and Cash Equivalents was U.S. $484 million as of year-end. We have an optimistic outlook for 2018 as we anticipate continuous M&G Mexico PET plant operations, PET margin recovery from the 2017 multi-year low and a higher annual average Brent oil price. 2018 Guidance will be disclosed tomorrow, prior to our 4Q17 Conference Call. ir@alpek.com www.alpek.com 3
Fourth Quarter 2017 (4Q17) Results by Business Segment Polyester (Purified Terephthalic Acid (PTA), Polyethylene Terephthalate (PET), Polyester fibers 71% of Alpek s Net Sales) Fourth quarter 2017 Polyester revenue was up 10% year-on-year and down 1% quarter-on-quarter amid a higher price environment. Average 4Q17 Polyester prices increased 9% and 3% when compared with 4Q16 and 3Q17, respectively, reflecting the rise in feedstock prices such as paraxylene. For the full-year 2017, revenue was up 8% versus 2016 as average prices increased 5% and volume was 3% higher. 4Q17 Polyester volume was flat when compared to 4Q16 and down 5% versus 3Q17. Lower PTA volume supplied to M&G in Mexico and Brazil were partially offset by incremental PET sales during 4Q17. In contrast, 2017 segment volume was 3% higher than in 2016 as the M&G PTA supply disruption was more than offset by the integration of Selenis Canada Inc. (PET), plus organic PET volume growth in the United States, Mexico and Argentina. Fourth quarter 2017 segment EBITDA was U.S. $77 million, including an U.S. $11 million non-cash inventory gain. Adjusting for inventory gains and the U.S. -$113 million M&G A/R provision in 3Q17, Comparable 4Q17 Polyester EBITDA was U.S. $66 million, flat when compared to 4Q16 and up 22% when compared with 3Q17. The M&G Mexico restart, PET margin recovery and a rising feedstock price environment contributed to Comparable Polyester EBITDA growth quarter-on-quarter. For the full-year 2017, Polyester EBITDA was U.S. $147 million, including the M&G A/R provision, a U.S. $14 million non-cash inventory gain and a U.S. $12 million one-time gain from the Selenis Canada Inc. acquisition (2016). Comparable 2017 Polyester EBITDA was U.S. $234 million, down 29% versus 2016 affected primarily by lower PET margins, the M&G PTA supply disruption and higher secondary feedstock costs (e.g. isophthalic acid or IPA). Plastics & Chemicals (P&C) (Polypropylene (PP), Expandable Polystyrene (EPS), Caprolactam (CPL), Other products 29% of Alpek s Net Sales) 4Q17 P&C revenue increased 17% year-on-year and 6% quarter-on-quarter due to higher average prices. Average fourth quarter 2017 P&C prices were up 15% and 6% when compared with 4Q16 and 3Q17 respectively, driven mainly by the rise in feedstock prices such as propylene and styrene. For the full year 2017, revenue grew 8% versus 2016 as lower volume was more than offset by an 11% increase in average prices. Fourth quarter 2017 P&C volume was up 1% year-on-year and flat when compared to 3Q17. On an annual basis, 2017 P&C volume was 3% lower than 2016 as unplanned refinery outages in Mexico weighed on propylene supply. Also, lower domestic ethylene oxide and ammonia supply affected Alpek s specialty chemical and caprolactam businesses. Segment EBITDA was U.S. $64 million in 4Q17, including a U.S. $5 million inventory gain. Adjusting for the inventory gain, Comparable 4Q17 P&C EBITDA was U.S. $59 million, up 12% and 9% when compared with 4Q16 and 3Q17 driven by PP and CPL. For the full-year 2017, P&C EBITDA was U.S. $237 million, including an U.S. $8 million noncash inventory gain. Comparable P&C EBITDA was U.S. $229 million, 26% lower than 2016 which benefited from record PP and EPS EBITDA. However, P&C EBITDA was consistently above 2017 Guidance. ir@alpek.com www.alpek.com 4
Fourth Quarter 2017 (4Q17) Consolidated Financial Results Net Sales: Net Sales for the fourth quarter totaled U.S. $1.3 billion, up 12% year-on-year and 1% quarter-onquarter, mainly due to higher average consolidated prices in both business segments. Average 4Q17 consolidated prices increased 11% and 5% when compared with 4Q16 and 3Q17, respectively. 4Q17 consolidated volume was up 1% year-on-year and down 4% quarter-on-quarter. Accumulated net sales as of December 31, 2017 totaled U.S. $5.2 billion, 8% higher than 2016 driven by increases of 6% and 2% in average prices and volume respectively. EBITDA: 4Q17 EBITDA was U.S. $141 million, including a U.S. $16 million non-cash inventory gain. Adjusting for the inventory gain, Comparable Consolidated EBITDA was U.S. $124 million, U.S. $108 million and U.S. $117 million in 4Q17, 3Q17 and 4Q16 respectively. Accumulated EBITDA as of December 31, 2017 was U.S. $384 million, including the U.S. -$113 million M&G A/R provision, a U.S. $22 million non-cash inventory gain and a U.S. $12 million one-time gain from the Selenis Canada Inc. acquisition (2016). Comparable Consolidated 2017 EBITDA totaled U.S. $462 million, down 27% versus 2016 mainly due to the anticipated margin contraction in PP and PET, plus the M&G PTA supply disruption. Profit (Loss) Attributable to Controlling Interest: Loss Attributable to Controlling Interest for the fourth quarter of 2017 was U.S. -$30 million due to higher Income tax and Fx loss. As a result of the recent U.S. tax reform, which lowered the corporate tax rate, 4Q17 Income tax includes a U.S. -$65 million adjustment to the U.S. $223 million deferred tax benefit related to M&G provisions and impairments. In addition, non-cash Fx loss totaled U.S. $47 million in 4Q17 due to the depreciation of the Mexican Peso. Accumulated 2017 Loss Attributable to Controlling Interest was U.S. -$319 million, including a net impact of U.S. -$481 million from non-recurring charges associated to M&G affecting EBITDA, Operating Income, Financial Cost, Net and Income Tax. Adjusting for the nonrecurring M&G items, the 2017 Profit Attributable to Controlling Interest was U.S. $162 million, compared to U.S. $198 million in 2016. Capital Expenditures and Acquisitions (Capex): 4Q17 Capex was U.S. $30 million, compared to U.S. $75 million and U.S. $64 million in 4Q16 and 3Q17 respectively. Year-to-date Capex of U.S. $236 million, 32% lower than the same period last year as investment ramps down due to the completion of Alpek s strategic project program. The majority of these funds were invested in the 350 MW power cogeneration plant in Altamira, Mexico, which advanced as planned. Net Debt: Consolidated Net Debt as of December 31, 2017 was U.S. $1.262 billion, up 21% and 6% year-on-year and quarter-on-quarter, respectively. On an absolute basis, Net Debt increased U.S. $70 million in 4Q17 as the investment of U.S. $101 million in M&G secured credit rights acquired from Inbursa was partially offset with cash from operations. As of December 31, 2017, Gross Debt was U.S. $1.747 billion and the Cash balance totaled U.S. $484 million. Financial ratios at the close of 4Q17 were: Net Debt to EBITDA of 3.3 times and Interest Coverage of 4.8 times. Adjusting for the U.S. -$113 million M&G A/R provision, Net Debt to EBITDA was 2.5 times and Interest Coverage was 6.2 times. ir@alpek.com www.alpek.com 5
Fourth Quarter 2017 (4Q17) Appendix A - Tables TABLE 1 VOLUME (KTONS) (%) 4Q17 vs. 4Q17 3Q17 4Q16 3Q17 4Q16 YTD17 YTD16 Ch.% Total Volume 975 1,012 970 (4) 1 4,012 3,938 2 Polyester 752 788 749 (5) - 3,105 3,004 3 Plastics and Chemicals 224 225 221-1 906 934 (3) TABLE 2 PRICE CHANGES (%) Polyester (%) 4Q17 vs. YTD17 vs. 3Q17 4Q16 YTD16 Avg. Ps. Prices 10 4 6 Avg. U.S. $ Prices 3 9 5 Plastics and Chemicals Avg. Ps. Prices 13 10 13 Avg. U.S. $ Prices 6 15 11 Total Avg. Ps. Prices 11 6 8 Avg. U.S. $ Prices 5 11 6 TABLE 3 INCOME STATEMENT (U.S. $ Millions) (%) 4Q17 vs. 4Q17 3Q17 4Q16 3Q17 4Q16 YTD17 YTD16 Ch.% Total Revenues 1,321 1,312 1,183 1 12 5,231 4,838 8 Gross Profit 162 126 142 29 15 544 714 (24) Operating expenses and others (52) (596) (44) 91 (19) (732) (182) (303) Operating income 110 (470) 98 123 13 (188) 532 (135) Financial cost, net (68) (130) (36) 47 (92) (188) (133) (41) Share of losses of associates - - - - - - - - Income Tax (62) 206 (29) (130) (111) 106 (126) 184 Consolidated net income (20) (394) 33 95 (161) (271) 272 (199) Controlling Interest (30) (400) 28 92 (209) (319) 198 (261) ir@alpek.com www.alpek.com 6
Fourth Quarter 2017 (4Q17) TABLE 4 REVENUES (%) 4Q17 vs. 4Q17 3Q17 4Q16 3Q17 4Q16 YTD17 YTD16 Ch.% Total Revenues Ps. Millions 25,010 23,374 23,428 7 7 98,998 90,192 10 U.S. $ Millions 1,321 1,312 1,183 1 12 5,231 4,838 8 Domestic Revenues Ps. Millions 8,166 8,060 8,491 1 (4) 34,957 33,625 4 U.S. $ Millions 431 452 429 (5) 1 1,846 1,806 2 Foreign Revenues Ps. Millions 16,844 15,314 14,937 10 13 64,042 56,567 13 U.S. $ Millions 890 859 754 4 18 3,385 3,032 12 Foreign / Total (%) 67 66 64 65 63 TABLE 5 OPERATING INCOME AND EBITDA Operating Income 4Q17 3Q17 4Q16 (%) 4Q17 vs. 3Q17 4Q16 YTD17 YTD16 Ch.% Ps. Millions 2,084 (8,377) 1,944 125 7 (2,854) 9,863 (129) U.S. $ Millions 110 (470) 98 123 13 (188) 532 (135) EBITDA Ps. Millions 2,660 59 2,647 4,408-7,483 12,425 (40) U.S. $ Millions 141 3 133 4,241 6 384 669 (43) TABLE 6 COMPARABLE EBITDA 4Q17 3Q17 4Q16 (%) 4Q17 vs. 3Q17 4Q16 YTD17 YTD16 Ch.% EBITDA Ps. Millions 2,660 59 2,647 4,408-7,483 12,425 (40) U.S. $ Millions 141 3 133 4,241 6 384 669 (43) Adjustments* Ps. Millions (309) 1,863 (327) (117) 5 1,322 (622) 312 U.S. $ Millions (16) 105 (16) (116) (1) 79 (32) 346 Comparable EBITDA Ps. Millions 2,350 1,922 2,320 22 1 8,806 11,803 (25) U.S. $ Millions 124 108 117 15 6 462 637 (27) *Adjustments: Inventory and non-operating, one-time (gains) losses ir@alpek.com www.alpek.com 7
Fourth Quarter 2017 (4Q17) TABLE 7 FINANCIAL COST, NET (U.S. $ Millions) (%) 4Q17 vs. 4Q17 3Q17 4Q16 3Q17 4Q16 YTD17 YTD16 Ch.% Financial Expenses (23) (19) (17) (24) (38) (78) (76) (3) Financial Income 2 2 4 13 (55) 10 15 (32) Net Financial Expenses (21) (17) (13) (25) (68) (68) (61) (11) Financial Assets Impairment - (95) - 100 - (95) - (100) Fx Gains (Losses) (47) (18) (23) (166) (105) (25) (72) 66 Financial Cost, Net (68) (130) (36) 47 (92) (188) (133) (41) TABLE 8 NET INCOME (U.S. $ Millions) 4Q17 3Q17 4Q16 (%)4Q17 vs. 3Q17 4Q16 YTD17 YTD16 Ch.% Consolidated Net Income (20) (394) 33 95 (161) (271) 272 (199) Non-Controlling Interest 10 6 5 65 94 49 75 (35) Controlling Interest (30) (400) 28 92 (209) (319) 198 (261) Earnings per Share (U.S. Dollars) (0.01) (0.19) 0.01 92 (209) (0.15) 0.09 (261) Avg. Outstanding Shares (Millions)* 2,117 2,117 2,117 2,117 2,117 * The same number of equivalent shares are considered in the periods presented TABLE 9 CASH FLOW (U.S. $ Millions) (%) 4Q17 vs. 4Q17 3Q17 4Q16 3Q17 4Q16 YTD17 YTD16 Ch.% EBITDA 141 3 133 4,241 6 384 669 (43) Net Working Capital & Others (37) 29 (84) (228) 55 83 (183) 145 Capital Expenditures & Acq. (30) (64) (75) 54 60 (236) (345) 32 Financial Expenses (22) (17) (16) (27) (35) (72) (58) (25) Income tax (9) (19) (22) 50 58 (87) (164) 47 Dividends (7) (71) (20) 90 64 (176) (225) 22 Payment affiliated companies - - 8 - (100) 1 68 (99) Other Sources / Uses (105) 5 (50) (2,325) (108) (118) (83) (42) Decrease (Increase) in Net Debt (70) (135) (127) 48 45 (221) (320) 31 ir@alpek.com www.alpek.com 8
Fourth Quarter 2017 (4Q17) TABLE 10 STATEMENT OF FINANCIAL POSITION & FINANCIAL RATIOS (U.S. $ Millions) (%) 4Q17 vs. 4Q17 3Q17 4Q16 3Q17 4Q16 Assets Cash and cash equivalents 484 447 142 8 241 Trade accounts receivable 544 507 542 7 0 Inventories 829 726 719 14 15 Other current assets 280 296 254 (5) 11 Total current assets 2,138 1,975 1,656 8 29 Investment in associates and others 33 33 28 1 18 Property, plant and equipment, net 2,105 2,117 1,970 (1) 7 Goodwill and intangible assets, net 206 211 575 (2) (64) Other non-current assets 270 227 200 19 35 Total assets 4,752 4,563 4,428 4 7 Liabilities & stockholders' equity Debt 375 380 135 (1) 178 Suppliers 874 741 636 18 37 Other current liabilities 170 186 168 (9) 1 Total current liabilities 1,420 1,307 939 9 51 Debt (include debt issuance cost) 1,366 1,254 1,043 9 31 Employees benefits 54 61 59 (12) (9) Other long term liabilities 308 312 367 (1) (16) Total liabilities 3,147 2,935 2,409 7 31 Total stockholders' equity 1,604 1,628 2,019 (1) (21) Total liabilities & stockholders' equity 4,752 4,563 4,428 4 7 Net Debt 1,262 1,192 1,042 6 21 Net Debt/EBITDA* 3.3 3.2 1.6 Interest Coverage* 4.8 5.4 10.5 * Times: last 12 months ir@alpek.com www.alpek.com 9
Fourth Quarter 2017 (4Q17) Polyester TABLE 11 REVENUES (%) 4Q17 vs. 4Q17 3Q17 4Q16 3Q17 4Q16 YTD17 YTD16 Ch.% Total Revenues Ps. Millions 17,668 16,836 16,862 5 5 70,477 64,241 10 U.S. $ Millions 933 945 851 (1) 10 3,724 3,444 8 Domestic Revenues Ps. Millions 3,679 4,108 4,473 (10) (18) 17,446 17,092 2 U.S. $ Millions 194 230 226 (16) (14) 921 917 - Foreign Revenues Ps. Millions 13,989 12,727 12,389 10 13 53,031 47,149 12 U.S. $ Millions 739 714 625 3 18 2,804 2,528 11 Foreign / Total (%) 79 76 73 75 73 TABLE 12 OPERATING INCOME AND EBITDA (%) 4Q17 vs. 4Q17 3Q17 4Q16 3Q17 4Q16 YTD17 YTD16 Ch.% Operating Income Ps. Millions 1,022 (9,208) 1,078 111 (5) (6,815) 4,487 (252) U.S. $ Millions 54 (517) 54 110 (0) (396) 241 (264) EBITDA Ps. Millions 1,467 (899) 1,640 263 (11) 2,970 6,514 (54) U.S. $ Millions 77 (51) 82 253 (6) 147 349 (58) TABLE 13 COMPARABLE EBITDA EBITDA 4Q17 3Q17 4Q16 (%) 4Q17 vs. 3Q17 4Q16 YTD17 YTD16 Ch.% Ps. Millions 1,467 (899) 1,640 263 (11) 2,970 6,514 (54) U.S. $ Millions 77 (51) 82 253 (6) 147 349 (58) Adjustments* Ps. Millions (215) 1,864 (327) (112) 34 1,489 (370) 503 U.S. $ Millions (11) 105 (16) (111) 30 87 (18) 574 Comparable EBITDA Ps. Millions 1,252 965 1,313 30 (5) 4,458 6,145 (27) U.S. $ Millions 66 54 66 22 (0) 234 331 (29) *Adjustments: Inventory and non-operating, one-time (gains) losses ir@alpek.com www.alpek.com 10
Fourth Quarter 2017 (4Q17) Plastics & Chemicals TABLE 14 REVENUES (%) 4Q17 vs. 4Q17 3Q17 4Q16 3Q17 4Q16 YTD17 YTD16 Ch.% Total Revenues Ps. Millions 7,342 6,538 6,566 12 12 28,522 25,951 10 U.S. $ Millions 388 367 332 6 17 1,506 1,394 8 Domestic Revenues Ps. Millions 4,487 3,952 4,018 14 12 17,511 16,533 6 U.S. $ Millions 237 222 203 7 17 925 890 4 Foreign Revenues Ps. Millions 2,855 2,587 2,548 10 12 11,011 9,418 17 U.S. $ Millions 151 145 129 4 17 581 505 15 Foreign / Total (%) 39 40 39 39 36 TABLE 15 OPERATING INCOME AND EBITDA (%) 4Q17 vs. 4Q17 3Q17 4Q16 3Q17 4Q16 YTD17 YTD16 Ch.% Operating Income Ps. Millions 1,071 832 898 29 19 3,966 5,413 (27) U.S. $ Millions 57 47 45 22 25 208 293 (29) EBITDA Ps. Millions 1,203 959 1,039 25 16 4,519 5,948 (24) U.S. $ Millions 64 54 52 18 21 237 322 (26) TABLE 16 COMPARABLE EBITDA EBITDA 4Q17 3Q17 4Q16 (%)4Q17 vs. 3Q17 4Q16 YTD17 YTD16 Ch.% Ps. Millions 1,203 959 1,039 25 16 4,519 5,948 (24) U.S. $ Millions 64 54 52 18 21 237 322 (26) Adjustments* Ps. Millions (94) (2) - (5,794) (100) (167) (253) 34 U.S. $ Millions (5) - - (100) (100) (8) (14) 41 Comparable EBITDA Ps. Millions 1,108 958 1,039 16 7 4,352 5,695 (24) U.S. $ Millions 59 54 52 9 12 229 308 (26) *Adjustments: Inventory and non-operating, one-time (gains) losses ir@alpek.com www.alpek.com 11
Fourth Quarter 2017 (4Q17) Appendix B Financial Statements ALPEK, S.A.B. DE C.V. and Subsidiaries STATEMENT OF FINANCIAL POSITION Information in Millions of Mexican Pesos (%) Dec 17 vs. Dec 17 Sep 17 Dec 16 Sep 17 Dec 16 ASSETS CURRENT ASSETS: Cash and cash equivalents 8,795 7,427 2,935 18 200 Trade accounts receivable 10,739 9,222 11,191 16 (4) Other accounts and notes receivable 4,152 3,938 3,626 5 15 Inventories 16,364 13,204 14,853 24 10 Other current assets 2,142 2,145 1,616 (0) 33 Total current assets 42,192 35,936 34,221 17 23 Investment in associates and others 650 594 575 9 13 Property, plant and equipment, net 41,535 38,518 40,699 8 2 Goodwill and intangible assets,net 4,065 3,845 11,875 6 (66) Other non-current assets 5,336 4,138 4,130 29 29 Total assets 93,778 83,031 91,500 13 2 LIABILITIES AND STOCKHOLDER'S EQUITY CURRENT LIABILITIES: Debt 7,408 6,910 2,787 7 166 Suppliers 17,255 13,493 13,151 28 31 Other current liabilities 3,356 3,385 3,469 (1) (3) Total current liabilities 28,019 23,788 19,407 18 44 NON-CURRENT LIABILITIES: Debt (include debt issuance cost) 26,958 22,818 21,551 18 25 Deferred income taxes 4,403 4,136 5,883 6 (25) Other liabilities 1,673 1,549 1,710 8 (2) Employees benefits 1,061 1,118 1,227 (5) (14) Total liabilities 62,114 53,409 49,778 16 25 STOCKHOLDERS EQUITY: Controlling interest: Capital stock 6,048 6,048 6,048 - - Share premium 9,071 9,071 9,071 - - Contributed capital 15,119 15,119 15,119 - - Earned surplus 11,797 10,153 21,954 16 (46) Total controlling interest 26,916 25,272 37,073 7 (27) Non-controlling interest 4,748 4,350 4,649 9 2 Total stockholders equity 31,664 29,622 41,722 7 (24) Total liabilities and stockholders equity 93,778 83,031 91,500 13 2 ir@alpek.com www.alpek.com 12
Fourth Quarter 2017 (4Q17) ALPEK, S.A.B. DE C.V. and Subsidiaries STATEMENT OF INCOME Information in Millions of Mexican Pesos 4Q17 vs.(%) YTD17 vs. (%) 4Q17 3Q17 4Q16 3Q17 4Q16 YTD17 YTD16 YTD16 Revenues 25,010 23,374 23,428 7 7 98,998 90,192 10 Domestic 8,166 8,061 8,491 1 (4) 34,957 33,625 4 Export 16,844 15,313 14,937 10 13 64,041 56,567 13 Cost of sales (21,941) (21,133) (20,615) (4) (6) (88,598) (76,943) (15) Gross profit 3,069 2,241 2,813 37 9 10,400 13,249 (22) Operating expenses and others (985) (10,618) (869) 91 (13) (13,254) (3,386) (291) Operating income 2,084 (8,377) 1,944 125 7 (2,854) 9,863 (129) Financial cost, net (1,296) (2,312) (719) 44 (80) (3,410) (2,509) (36) Share of losses of associates - 1 2 (78) (89) (4) (3) (24) Profit (loss) before income tax 788 (10,688) 1,227 107 (36) (6,268) 7,351 (185) Income tax (1,173) 3,668 (582) (132) (102) 1,713 (2,358) 173 Consolidated net income (loss) (385) (7,020) 645 95 (160) (4,555) 4,993 (191) Profit (loss) attributable to Controlling interest (577) (7,130) 544 92 (206) (5,487) 3,625 (251) Profit attributable to Non-controlling interest 192 110 101 75 90 932 1,368 (32) ir@alpek.com www.alpek.com 13
Nemak reports 4Q17 results - Quarterly revenues and EBITDA of US$1.1 billion and US$166 million, respectively - New contracts awarded to Nemak for US$130 million in annual revenues Monterrey, Mexico. February 12, 2018. - Nemak, S.A.B. de C.V. ( Nemak ) (BMV: NEMAK), a leading provider of innovative lightweighting solutions for the global automotive industry, announced today its operational and financial results for the fourth quarter of 2017 ("4Q17"). What follows is an overview of the quarter s main highlights: Key Figures For 4Q17, volumes were 12.0 million equivalent units ("MEU"), 1.7% higher year-over-year ("y-oy"), with Europe ("EU") showing healthy growth and North America ("NA") and Rest of World ("RoW") remaining stable. In turn, revenues were US$1,094 million, up 9.8% y-o-y on the back of higher average aluminum prices plus higher volumes. Full-year volumes were 49.9 MEU, down slightly vis-a-vis 2016, while revenues were US$ 4,481 million, up 5.3% due to higher aluminum prices. 4Q17 EBITDA was US$166 million, a 10.8% y-o-y decrease mainly due to the combined effect of negative metal price lag and higher launching expenses. EU was the company s top-performing region, reporting improved profitability due to increased sales of higher value-added products. On a cumulative basis, EBITDA for the full year was US$715 million, 10.4% lower than last year due to the same factors behind quarterly y-o-y variations. 4Q17 capex was US$109 million as the company continued with investments to increase and adapt production capacity to meet new demand related to recently awarded contracts. Likewise, resources were invested in the continued launch of new programs to produce structural and electric vehicle components ("SC/EV") in NA and EU. For the full year of 2017, capex amounted to US$433 million. February 12, 2018 1
Message from the CEO We reached key milestones in the implementation of our strategy, securing new contracts that will position us to provide higher value-added solutions to our customers while continuing to advance with the ramp-up of our SC/EV operations. Our solid efforts in our SC/EV business throughout the year enabled us to generate annual revenues in this segment of approximately US$100 million. While quarterly consolidated volumes finished slightly higher, our profitability decreased mainly due to external headwinds in particular, rising aluminum prices combined with increased launching expenses. Building on our customer relationships, we were awarded new contracts across all business lines worth a total of US$130 million in annual revenues in the quarter. For the full 2017 year, new contract wins totaled US$830 million in annual revenues, similar to the amount secured the previous year. We also took important steps to strengthen our financial position, issuing a US$500 million bond in the international debt markets in January, 2018 that will enable us to lower our financial costs and to extend the average life of our debt. The notes featured the all-time lowest coupon 4.75% for a Ba1/BB+/BB+ rated issuance from a Latin American company. Automotive Industry In the quarter, SAAR for U.S. vehicle sales was down 1.6% y-o-y, with retail sales remaining stable while fleet sales decreased. In turn, North America vehicle production and Nemak customers vehicle production decreased 4.1% and 5.8%, respectively, as OEMs reduced inventories. In Europe, vehicle sales SAAR in 4Q17 decreased 1.4% y-o-y due to lower sales in Western Europe. Nonetheless, vehicle production and Nemak customers production increased 7.9 and 10.3%, respectively, supported by increased production of vehicles for export to other regions. February 12, 2018 2
Recent Developments Nemak won two new SC/EV programs: one marking its entry into this segment in China; and one representing its first full assembly solution for a premium OEM in Europe. Total order book in the SC/EV business grew to approximately US$320 million in annual revenues. Selected as a winner of the 2017 R&D 100 Awards for the co-development of a new hightemperature aluminum alloy together with FCA and Oak Ridge National Laboratory. Named as a finalist for the 2018 Automotive News Pace Awards for the development of its lightweight Rotacast aluminum casting process. The winners will be announced next April. Financial Results Summary What follows is an explanation of the results shown in the table above: 4Q17 total volume increased by 1.7% y-o-y driven by higher customer demand in Europe for Nemak components. In this region, 4Q17 volume increased 5.6% y-o-y reflecting the strength of the market. Meanwhile, North America volumes remained steady as new program launches compensated for lower customer production. Likewise in RoW, where industry recovery in South America compensated for lower customer demand in Asia for Nemak components. For the full 2017 year, Nemak s overall volume decreased slightly vis-à-vis 2016 as lower volumes in NA narrowly outweighed growth in EU and RoW. Turning to revenues, higher aluminum prices combined with volumes drove Nemak s 4Q17 consolidated revenues up 9.8% y-o-y. For the full year, rising aluminum prices more than compensated for lower volumes, causing revenues to increase 5.3% vis-à-vis 2016. 4Q17 operating income decreased 26.7% y-o-y, mainly as a result of negative metal price lag and increased expenses related to new program launches. Lower operating income translated into an operating margin of 6.0%, 300 basis points below 4Q16. For full-year 2017, operating income was 21.1% lower than 2016 due to the same reasons already explained, which in turn caused operating margin to decrease 280 basis points. The above-mentioned decrease in 4Q17 operating income resulted in a 10.8% y-o-y reduction in EBITDA. 4Q17 EBITDA margin was 15.2%, down from the 18.7% reported in 4Q16. 4Q17 EBITDA per equivalent unit was US$13.80, down from US$15.80 in 4Q16. For full-year 2017, the already explained lower operating income caused EBITDA to finish 10.4% lower than in 2016. In turn, February 12, 2018 3
EBITDA margin and EBITDA per equivalent unit were 16.0% and US$14.30, respectively, which compared to 18.7% and US$15.90 the previous year. 4Q17 net income decreased 40.0% compared to 4Q16 mainly due to lower operating income combined with foreign exchange losses. Full-year net income was 34.2% lower than in 2016 for the same reasons. Capital expenditures totaled US$109 million during 4Q17. As explained, investments were made to expand capacity and to facilitate operational efficiency across the company s regions. Capital expenditures for the year amounted to US$433 million. As of December 31, 2017, Nemak reported Net Debt in the amount of US$1.3 billion, including Cash and Marketable Securities worth US$190 million. Financial ratios were: Debt, net of Cash, to EBITDA, 1.78 times; and Interest Coverage, 11.2 times. These ratios are similar to those reported at the end of 2016. Regional Results North America In 4Q17, revenues increased 7.3% y-o-y due to higher aluminum prices. Turning to EBITDA, the adverse impact of metal price lag and increased launching expenses were the main causes of the 22.7% decrease y-o-y. For full-year 2017, revenues increased 0.2% vis-a-vis 2016 while EBITDA decreased 17.2%, for the same reasons. Europe In 4Q17, revenues increased 19.4% y-o-y driven by new program launches and higher aluminum prices. Meanwhile, 4Q17 EBITDA increased 12.7% y-o-y, as higher volumes and an improved sales mix more than compensated for the effects of negative metal price lag. For the full year, revenues increased 9.8% on the back of higher aluminum prices and higher volumes. However, EBITDA decreased 1.3% as higher revenues were not enough to offset negative metal price lag. Rest of the World (RoW) In 4Q17, revenues in RoW decreased by 7.8% y-o-y mainly due to a less favorable sales mix; nonetheless, both volume and EBITDA in the period were flat. In 2017, revenues in RoW increased 22.2% compared to 2016 mainly due to higher volumes and a better product mix across Asia and South America. EBITDA in RoW increased US$12 million in 2017 compared to 2016 for the same reasons. ------------------ February 12, 2018 4
Methodology for presentation of results The report presents unaudited financial information. Figures are in Mexican pesos or U.S. dollars, as indicated. For income statements, peso amounts were translated into dollars using the average exchange rate of the months during which the operations were recorded. For balance sheets, peso amounts were translated into dollars using the end-of-period exchange rate. Financial ratios were calculated in dollars. Due to rounding, small differences may occur when calculating percent changes from one period to another. Conference call information Nemak s Fourth Quarter 2017 Conference Call will be held on Tuesday, February 13, 2018, 11:30 a.m. Eastern Time (10:30 a.m. Mexico City Time). To participate in the conference call, please dial: Domestic U.S.: (877) 407-0784; International: 1-201-689-8560; Mexico Toll Free: 01 800 522 0034. The conference call will be webcast live through streaming audio. If you are unable to participate, the conference call audio and script will be available on Nemak s website. For more information, please visit investors.nemak.com Forward-looking statements This report may contain certain forward-looking statements concerning Nemak s future performance that should be considered as good faith estimates made by the Company. These forward-looking statements reflect management s expectations and are based upon currently available data and analysis. Actual results are subject to future events and uncertainties, which could materially impact Nemak s actual performance and results. About Nemak Nemak is a leading provider of innovative lightweighting solutions for the global automotive industry, specializing in the development and manufacturing of aluminum components for powertrain and body structure applications. The company employs more than 22,000 people at 38 facilities worldwide. In 2017, it generated revenues of US$4.5 billion. For more information about Nemak, visit http://www.nemak.com Three pages of tables to follow February 12, 2018 5
February 12, 2018 6
February 12, 2018 7
February 12, 2018 8
4th Quarter 2017 San Pedro Garza Garcia, Mexico, February 12, 2018 - Axtel, S.A.B. de C.V. ( Axtel or the Company ), a Mexican Information and Communications Technology company, announced today its unaudited fourth quarter results ended December 31, 2017 (1). Results presented on this report reflect figures consolidated under Alfa S.A.B. de C.V. The complete unaudited fourth quarter results of Axtel have been filed with the Mexican Stock Exchange and are also available at the Company s website, axtelcorp.mx. (%) 4Q17 vs. YTD 4Q17 3Q17 4Q16 YTD'17 YTD'16 In millions 3Q17 4Q16 Δ% Revenues (Ps.) 4,286 3,764 3,783 14% 13% 15,513 13,744 13% In USD 226 211 191 7% 19% 822 736 12% EBITDA (Ps.) (5) 1,450 1,317 910 10% 59% 5,451 4,177 30% In USD 77 74 46 4% 66% 290 225 29% Net (loss) Income (Ps.) -923-632 -1,055-46% 12% 62-2,283 n.a. In USD -49-36 -52-37% 5% 1-117 n.a. Capital Expenditures (Ps.) 784 748 885 5% -11% 3,032 3,581-15% In USD 41 42 45-1% -7% 160 210-24% Net Debt (In USD) 973 1,029 972-5% 0% Net Debt / EBITDA (6) 3.4x 4.0x 4.6x Note: Financial information presented throughout this report includes unaudited consolidated results for Alestra S. de R.L. de C.V. and its subsidiaries ( Alestra ) up to February 14th, 2016, and for Axtel and its subsidiaries, including Alestra, from February 15th, 2016, and thereafter. Highlights: v Fourth quarter results validated Axtel s commitment to the strategy put in place after the merger; continue delivering IT and Telecom solutions to enterprise and government clients with the highest quality and service standards. In peso terms, quarterly revenues increased 13% year-over-year mainly due to an 18% increase in Enterprise and Government segment revenues; finishing off a strong year where revenues and EBITDA increased 5% and 38% respectively, compared to pro forma 2016, providing a solid base for 2018. v In the fourth quarter, Axtel successfully executed its refinancing strategy, issuing a US$500 million, 7-year bond and, in December, receiving a Ps. 6,000 million 5-year loan. Proceeds from these two transactions were used to prepay the existing syndicated bank loan. This refinancing extended the average life of the Company s debt to over 5 years and provided further covenant flexibility, while maintaining the peso/dollar debt mix. v During the quarter, Axtel executed the third phase of its Tower Sale agreement with American Towers Corporation, receiving US$18 million in net proceeds. Axtel also continued supplying infrastructure and services to ALTAN under its vendor agreement, working towards completing the Red Compartida s population coverage goal of 30% by March 2018. Media Relations: Julio Salinas contacto@axtel.com.mx +52(81) 8114-1144 Investor Relations: Nancy Llovera IR@axtel.com.mx +52(81) 8114-1128 Patricio Jiménez IR@axtel.com.mx +52(81) 8114-1128